Moving beyond multimorbidity as a simple count of diseases

Journal of Evaluation in Clinical Practice

Volumn 23, Issue 1, 2017, Pages 216-218

  Melis, René J F ^a   Gijzel, Sanne M W ^a   Olde Rikkert, Marcel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CHRONIC DISEASE; DISEASES; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HYPOTHESIS; KNOWLEDGE; MORBIDITY; MULTIMORBIDITY; NOTE; PHENOTYPE; STRESS; SYMPTOMATOLOGY; COMORBIDITY; PRIMARY HEALTH CARE;

CHRONIC DISEASE; COMORBIDITY; HUMANS; PRIMARY HEALTH CARE;

EID: 85007560412     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12693     Document Type: Note

References (21)

1. Sturmberg JP, Bennett JM, Martin CM, Picard M. 'Multimorbidity' as the manifestation of network disturbances. J Eval Clin Pract. 2017;23(1):199–208.
2. Hilliard AA, Weinberger SE, Tierney LM Jr, Midthun DE, Saint S. Clinical problem-solving. Occam's razor versus Saint's Triad. N Engl J Med. 2004;350(6):599–603.
3. van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract. 1996;2(2):65–70.
4. Ellis GF. Top-down causation and emergence: some comments on mechanisms. Interface Focus. 2012;2(1):126–140.
5. Marcum JA. Multimorbidity, P4 medicine and holism. J Eval Clin Pract. 2017;23(1):213–215.
6. Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254–266.
7. Implementation of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Epidemiol Bull. 1997;18(1):1–4.
8. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56–68.
9. Joyner MJ, Paneth N, Ioannidis JP. What happens when underperforming big ideas in research become entrenched? JAMA. 2016;316(13):1355–1356.
10. Grimley Evans J. Prevention of age-associated loss of autonomy: epidemiological approaches. J Chronic Dis. 1984;37(5):353–363.
11. Troncale JA. The aging process. Physiologic changes and pharmacologic implications. Postgrad Med. 1996;99(5):111–114, 20-2.
12. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98(8):4770–4775.
13. Clegg A, Young J, Iliffe S, Olde Rikkert MGM, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–762.
14. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–363.
15. Cohen AA. Complex systems dynamics in aging: new evidence, continuing questions. Biogerontology. 2016;17(1):205–220.
16. Marzetti E, Calvani R, Landi F, et al. Innovative medicines initiative: the SPRINT project. J Frailty Aging. 2015;4(4):207–208.
17. Smith GD. Epidemiology, epigenetics and the ‘gloomy prospect’: embracing randomness in population health research and practice. Int J Epidemiol. 2011;40(3):537–562.
18. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–724.
19. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–1240.
20. Plsek PE, Greenhalgh T. Complexity science: the challenge of complexity in health care. BMJ. 2001;323(7313):625–628.
21. Van Beurden EK, Kia AM, Zask A, Dietrich U, Rose L. Making sense in a complex landscape: how the cynefin framework from complex adaptive systems theory can inform health promotion practice. Health Promot Int. 2013;28(1):73–83.